{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:55:13Z","timestamp":1782863713248,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,26]]},"DOI":"10.7759\/cureus.84846","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:22:03Z","timestamp":1748280123000},"source":"Crossref","is-referenced-by-count":2,"title":["Postoperative Anticoagulation After Mitral Bioprosthetic Valve Surgery: A Systematic Review and Meta-Analysis of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin"],"prefix":"10.7759","author":[{"given":"Moiuz","family":"Chaudhri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ellebedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed D","family":"Al Mahrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranesh","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kaunzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad R","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021, 143:e72-e227. 10.1161\/CIR.0000000000000923","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo VT","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006, 368:1005-11. 10.1016\/S0140-6736(06)69208-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013332","article-title":"Early experience with transcatheter mitral valve replacement: a systematic review","volume":"8","author":"Del Val D","year":"2019","unstructured":"Del Val D, Ferreira-Neto AN, Wintzer-Wehekind J, et al.. Early experience with transcatheter mitral valve replacement: a systematic review. J Am Heart Assoc. 2019, 8:e013332. 10.1161\/JAHA.119.013332","journal-title":"J Am Heart Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S16420","article-title":"Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement","volume":"5","author":"Tillquist MN","year":"2011","unstructured":"Tillquist MN, Maddox TM. Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement. Patient Prefer Adherence. 2011, 5:91-9. 10.2147\/PPA.S16420","journal-title":"Patient Prefer Adherence"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.621258","article-title":"Transcatheter mitral valve replacement and thrombosis: a review","volume":"8","author":"Ascione G","year":"2021","unstructured":"Ascione G, Denti P. Transcatheter mitral valve replacement and thrombosis: a review. Front Cardiovasc Med. 2021, 8:621258. 10.3389\/fcvm.2021.621258","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"60","author":"Vahanian A","year":"2021","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al.. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021, 60:727-800. 10.1093\/ejcts\/ezab389","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"77","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2021, 77:e25-e197. 10.1016\/j.jacc.2020.11.018","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168531","article-title":"The clinical significance of drug-food interactions of direct oral anticoagulants","volume":"22","author":"Grze\u015bk G","year":"2021","unstructured":"Grze\u015bk G, Rogowicz D, Wo\u0142owiec \u0141, et al.. The clinical significance of drug-food interactions of direct oral anticoagulants. Int J Mol Sci. 2021, 22:68531. 10.3390\/ijms22168531","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimar\u00e3es HP","year":"2020","unstructured":"Guimar\u00e3es HP, Lopes RD, de Barros E Silva PG, et al.. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med. 2020, 383:2117-26. 10.1056\/NEJMoa2029603","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2021.12.022","article-title":"Commentary: developing accurate tools for predicting outcomes following coronary artery bypass graft surgery: more data are needed","volume":"166","author":"Lazar HL","year":"2023","unstructured":"Lazar HL. Commentary: developing accurate tools for predicting outcomes following coronary artery bypass graft surgery: more data are needed. J Thorac Cardiovasc Surg. 2023, 166:801-4. 10.1016\/j.jtcvs.2021.12.022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac556","article-title":"Convergent procedure for non-paroxysmal atrial fibrillation: a light in the darkness","volume":"63","author":"Onorati F","year":"2022","unstructured":"Onorati F, Francica A, Tonelli F, Luciani GB. Convergent procedure for non-paroxysmal atrial fibrillation: a light in the darkness. Eur J Cardiothorac Surg. 2022, 63:556. 10.1093\/ejcts\/ezac556","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivab351","article-title":"Early aortic growth in acute descending aortic dissection","volume":"34","author":"Berezowski M","year":"2022","unstructured":"Berezowski M, Scheumann J, Beyersdorf F, et al.. Early aortic growth in acute descending aortic dissection. Interact Cardiovasc Thorac Surg. 2022, 34:857-64. 10.1093\/icvts\/ivab351","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2023.05.025","article-title":"Long-term outcomes and anticoagulation in mitral valve surgery - a report from the society of thoracic surgeons database","volume":"116","author":"Schwann TA","year":"2023","unstructured":"Schwann TA, Vekstein AM, Engelman DT, et al.. Long-term outcomes and anticoagulation in mitral valve surgery - a report from the society of thoracic surgeons database. Ann Thorac Surg. 2023, 116:944-53. 10.1016\/j.athoracsur.2023.05.025","journal-title":"Ann Thorac Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615261","article-title":"Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves\/prior surgical valve repair: a multicenter clinical practice experience","volume":"44","author":"Russo V","year":"2018","unstructured":"Russo V, Attena E, Mazzone C, et al.. Nonvitamin K antagonist oral anticoagulants use in patients with atrial fibrillation and bioprosthetic heart valves\/prior surgical valve repair: a multicenter clinical practice experience. Semin Thromb Hemost. 2018, 44:364-9. 10.1055\/s-0037-1615261","journal-title":"Semin Thromb Hemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00939-x","article-title":"Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements","volume":"40","author":"Pasciolla S","year":"2020","unstructured":"Pasciolla S, Zizza LF, Le T, Wright K. Comparison of the efficacy and safety of direct oral anticoagulants and warfarin after bioprosthetic valve replacements. Clin Drug Investig. 2020, 40:839-45. 10.1007\/s40261-020-00939-x","journal-title":"Clin Drug Investig"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2024.02.013","article-title":"Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery","volume":"43","author":"Costa H","year":"2024","unstructured":"Costa H, Cust\u00f3dio P, Baptista Gon\u00e7alves R, Lamares Magro P, Sousa Uva M. Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery. Rev Port Cardiol. 2024, 43:501-9. 10.1016\/j.repc.2024.02.013","journal-title":"Rev Port Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-016-0124-1","article-title":"Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot study","volume":"16","author":"Dur\u00e3es AR","year":"2016","unstructured":"Dur\u00e3es AR, de Souza Roriz P, de Almeida Nunes B, Albuquerque FP, de Bulh\u00f5es FV, de Souza Fernandes AM, Aras R. Dabigatran versus warfarin after bioprosthesis valve replacement for the management of atrial fibrillation postoperatively: DAWA pilot study. Drugs R D. 2016, 16:149-54. 10.1007\/s40268-016-0124-1","journal-title":"Drugs R D"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/87551225211021596","article-title":"Safety and efficacy of apixaban following bioprosthetic valve replacements: a retrospective evaluation","volume":"37","author":"Ball K","year":"2021","unstructured":"Ball K, Covington EW. Safety and efficacy of apixaban following bioprosthetic valve replacements: a retrospective evaluation. J Pharm Technol. 2021, 37:193-201. 10.1177\/87551225211021596","journal-title":"J Pharm Technol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.10.031","article-title":"Comparison of direct oral anticoagulants vs vitamin K antagonists after transcatheter mitral valve replacement","volume":"83","author":"El B\u00e8ze N","year":"2024","unstructured":"El B\u00e8ze N, Himbert D, Suc G, et al.. Comparison of direct oral anticoagulants vs vitamin K antagonists after transcatheter mitral valve replacement. J Am Coll Cardiol. 2024, 83:334-46. 10.1016\/j.jacc.2023.10.031","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom JW","year":"2017","unstructured":"Eikelboom JW, Connolly SJ, Bosch J, et al.. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017, 377:1319-30. 10.1056\/NEJMoa1709118","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivab363","article-title":"Are NOACs as safe and efficient as VKA regarding thromboembolic prophylaxis and major bleeding in patients with surgical bioprosthesis and atrial fibrillation within 3 months of surgery?","volume":"34","author":"Magro PL","year":"2022","unstructured":"Magro PL, Sousa-Uva M. Are NOACs as safe and efficient as VKA regarding thromboembolic prophylaxis and major bleeding in patients with surgical bioprosthesis and atrial fibrillation within 3 months of surgery?. Interact Cardiovasc Thorac Surg. 2022, 34:739-43. 10.1093\/icvts\/ivab363","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2021.01.127","article-title":"Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial","volume":"165","author":"Shim CY","year":"2023","unstructured":"Shim CY, Seo J, Kim YJ, Lee SH, De Caterina R, Lee S, Hong GR. Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: a randomized clinical trial. J Thorac Cardiovasc Surg. 2023, 165:58-67.e4. 10.1016\/j.jtcvs.2021.01.127","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.0364","article-title":"Laboratory monitoring of non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation: a review","volume":"2","author":"Eikelboom JW","year":"2017","unstructured":"Eikelboom JW, Quinlan DJ, Hirsh J, Connolly SJ, Weitz JI. Laboratory monitoring of non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation: a review. JAMA Cardiol. 2017, 2:566-74. 10.1001\/jamacardio.2017.0364","journal-title":"JAMA Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezad013","article-title":"Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset","volume":"63","author":"Loforte A","year":"2023","unstructured":"Loforte A, Nersesian G, Lewin D, et al.. Impact of preoperative mitral regurgitation on left ventricular assist device patients: propensity score-matched analysis of the EUROMACS dataset. Eur J Cardiothorac Surg. 2023, 63:ezad013. 10.1093\/ejcts\/ezad013","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371309-postoperative-anticoagulation-after-mitral-bioprosthetic-valve-surgery-a-systematic-review-and-meta-analysis-of-non-vitamin-k-antagonist-oral-anticoagulants-versus-warfarin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:22:03Z","timestamp":1748280123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371309-postoperative-anticoagulation-after-mitral-bioprosthetic-valve-surgery-a-systematic-review-and-meta-analysis-of-non-vitamin-k-antagonist-oral-anticoagulants-versus-warfarin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.84846","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}